Ondansetron and Domperidone Combination Risks

Primary Safety Concerns

• The French Society for Oncology Pharmacy explicitly contraindicates the combination of ondansetron (>8mg) with domperidone when hydroxychloroquine is used, specifically citing torsade de pointes risk, and recommends replacing domperidone with metomimazine in such scenarios, indicating domperidone's problematic cardiac profile 1

Alternative Antiemetic Strategies

• The National Comprehensive Cancer Network recommends metoclopramide or prochlorperazine as first-line antiemetics, with monitoring for akathisia, and dexamethasone can be added for synergistic antiemetic effect without QT concerns 2
• Olanzapine is particularly helpful in specific situations like bowel obstruction 2

Safe Usage Guidelines

• Limit ondansetron to 8mg maximum to minimize QT risk 1, 3
• Avoid domperidone entirely and substitute with metoclopramide (10-20mg) or prochlorperazine instead 2, 3
• Obtain baseline ECG to assess QT interval, especially if cardiac risk factors are present 2, 3
• Check and correct electrolytes (potassium and magnesium) before initiating therapy, as abnormalities enhance cardiac toxicity 2, 3

High-Risk Patient Populations

• Avoid the combination of ondansetron and domperidone entirely in patients with pre-existing cardiac conditions or prolonged QT interval 2
• Avoid the combination in patients with concomitant use of other QT-prolonging medications 1, 2
• Avoid the combination in patients with electrolyte abnormalities (hypokalemia, hypomagnesemia) 1, 2
• Avoid the combination in patients with bradycardia or heart block 1